Completed PHASE4 INTERVENTIONAL 2-arm NCT03323164

Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study

Changes in Peripapillary Blood Flow After Use of Anti-glaucoma Medications: A Prospective, Quantitative OCT Angiography Study

Sponsor: Optovue

Conditions Glaucoma; Drugs Normal Tension Glaucoma Primary Open-angle Glaucoma

Interventions Brimonidine Tartrate Timolol Maleate

Updated 9 times since 2017 Last updated: Dec 4, 2020 Started: Jul 10, 2017 Primary completion: Dec 31, 2018 Completion: May 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Glaucoma; Drugs and Normal Tension Glaucoma, this trial is completed. The trial is conducted by Optovue and has accumulated 9 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Dec 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Dec 2021 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed
Aug 2019 — Jan 2021 [monthly]

Active Not Recruiting PHASE4

▶ Show 4 earlier versions

Mar 2019 — Aug 2019 [monthly]

Active Not Recruiting PHASE4
Jul 2018 — Mar 2019 [monthly]

Active Not Recruiting PHASE4

Status: Recruiting → Active Not Recruiting
Jun 2018 — Jul 2018 [monthly]

Recruiting PHASE4
Nov 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Jul 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Optovue
Wills Eye

Data source: Wills Eye

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States